Yahoo Web Search

Search results

1. www.lilly.comA Medicine Company | Eli Lilly and Company

   www.lilly.com

   We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.

   • Investor Relations

     The Investor Relations website contains information about...

     Webcasts & Presentations

     · SEC Filings

     · Quarterly Results

     · Individual Investors

     · Stock Quote & Chart

     · Key Ratios

   • Contact

     If you are having trouble paying for a prescription for your...

   • Trials

     Whether it's treating rare tumor types, leveraging precision...

     Find Lilly Clinical Trials

     · Clinical Trial Information

     · Blog

     · Healthcare Professionals

     · Cancer Research

   • Who We Are

     We’re a medicine company turning science into healing to...

   • Press Releases

     INDIANAPOLIS , May 28, 2024 /PRNewswire/ -- Eli Lilly and...

   • Suppliers

     Supplier relationships are an important piece of the...

     Prospective Suppliers

     · Supplier Resources

2. Images

   • 
   • 
   • 
   • 

   View all

3. Top Stories

   • 

     Business Insider on MSN.com

     Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

     2 days ago

   • Benzinga.com

     Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect

     QurAlis granted Lilly an exclusive, worldwide license to develop and commercialize QRL-204. The agreement includes a research and development collaboration to identify and develop additional candidates targeting UNC13A. QurAlis has granted Lilly global ...

     5 hours ago

   • 

     Time

     Eli Lilly

     4 days ago

   • Yahoo

     Relaxing with Lilly: Pulitzer-branded suite a first for Eau Palm Beach Resort

     7 hours ago

   • FierceBiotech

     Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect

     Eli Lilly is splicing another asset onto its neurodegenerative disease pipeline, paying QurAlis $45 million for rights to a preclinical treatment for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The deal gives Lilly global rights ...

     14 hours ago

   View all

4. www.lilly.com › disease-areas › diabetesDiabetes Medications and Support Programs | Eli Lilly and Company

   www.lilly.com › disease-areas › diabetes

   For more than 90 years, Lilly has been committed to diabetes and meeting the needs of people affected by diabetes with treatment options, support programs and more.

5. en.wikipedia.org › wiki › Eli_Lilly_and_CompanyEli Lilly and Company - Wikipedia

   en.wikipedia.org › wiki › Eli_Lilly_and_Company

   • Cached

   As of 2022, Lilly is known for its clinical depression drugs Prozac ( fluoxetine) (1986), Cymbalta ( duloxetine) (2004), and its antipsychotic medication Zyprexa ( olanzapine) (1996), although its primary revenue drivers are the diabetes drugs Humalog ( insulin lispro) (1996) and Trulicity ( dulaglutide) (2014). [5]

6. investor.lilly.com › news-releases › news-releaseLilly Increases Manufacturing Investment to $9 Billion at ...

   investor.lilly.com › news-releases › news-release

   • Cached

   May 24, 2024 · "Lilly's commitment to meeting the demand for our life-changing medicines goes beyond buildings and extends to improving education opportunities and upskilling a global workforce of the future," said Edgardo Hernandez, executive vice president and president, Lilly Manufacturing Operations. "Academia is a critical partner to both industry and ...

7. www.cnbc.com › 2024/05/24 › eli-lilly-invests-toEli Lilly invests to increase Mounjaro, Zepbound supply

   www.cnbc.com › 2024/05/24 › eli-lilly-invests-to

   • Cached

   May 24, 2024 · An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant ...